Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive value of PfEMP1 antibody profiles for the course of controlled human malaria infections.

PLoS pathogens·2026
Same author

Correction: Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression.

PLoS pathogens·2026
Same author

Immunization strategies to prevent malaria in pregnancy - a multistakeholder workshop.

Vaccine·2026
Same author

Controlled human pneumococcal infection in the Netherlands: Colonisation, antibody responses and the impact of viral co-infection.

The Journal of infection·2026
Same author

IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection.

The American journal of tropical medicine and hygiene·2025
Same author

Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil.

EMBO molecular medicine·2025

Related Experiment Video

Updated: Jun 14, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

New medicines for malaria.

Benjamin Mordmüller1

  • 1Institut für Tropenmedizin, Eberhard Karls Universität Tübingen, Tübingen, Germany. benjamin.mordmueller@uni-tuebingen.de

Wiener Klinische Wochenschrift
|April 9, 2010
PubMed
Summary
This summary is machine-generated.

Developing new malaria medicines and vaccines is crucial as parasites evolve resistance. This research explores innovative strategies to overcome drug and vaccine resistance in malaria interventions.

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

Related Experiment Videos

Last Updated: Jun 14, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

Area of Science:

  • * Malariology and Tropical Medicine
  • * Pharmaceutical Development and Vaccine Research

Background:

  • * Malaria parasite resistance to drugs like chloroquine, sulfadoxine-pyrimethamine (SP), and artemisinins necessitates novel interventions.
  • * Development of effective malaria vaccines has been a long-standing challenge, with recent efforts showing modest but significant progress.

Purpose of the Study:

  • * To summarize fundamental principles guiding research in malaria intervention development.
  • * To present current projects focused on overcoming drug and vaccine resistance in malaria.

Main Methods:

  • * Review of existing literature on antimalarial drug and vaccine efficacy.
  • * Description of novel research methodologies employed by the group.
  • * Case studies illustrating the application of these principles in ongoing projects.

Main Results:

  • * Analysis of parasite adaptation mechanisms driving resistance to current therapies.
  • * Evaluation of promising vaccine candidates and their efficacy data.
  • * Insights into the challenges and successes of developing new malaria interventions.

Conclusions:

  • * Continuous innovation is essential to combat evolving malaria parasite resistance.
  • * A multi-pronged approach combining drug development and vaccine research is vital for malaria control.
  • * Further research and development are needed to achieve a registered and effective malaria vaccine.